NewYork-Presbyterian/Weill Cornell Medical Center 525 East 68Th Street, New York, NY 10065
Education:
Medical School Yale University School Of Medicine Graduated: 1990 Medical School Johns Hopkins Graduated: 1991 Medical School Johns Hopkins Graduated: 1992 Medical School Brigham and Women's Hospital Graduated: 1996 Medical School Harvard Dept Med and Genetics Graduated: 1996
Craig Basson, New York NY
Work:
Cornell Internal Med Assoc
520 E 70Th St, New York, NY 10021
Yale University, School of Medicine - Doctor of Medicine Yale University, School of Medicine - Doctor of Philosophy Brigham & Women's Hospital - Fellowship - Cardiology Massachusetts General Hospital - Fellowship - Research
Board certifications:
American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Us Patents
Transcription Factors That Regulate Normal And Malignant Cell Growth
The invention provides TBX5 protein fragments that regulate normal and malignant cell growth and nucleic acids encoding these fragments. Such protein fragments include a translated 5′ T-box sequence capable of binding to the major groove of target DNA and lack a translated 3′ T-box sequence that binds to target DNA's minor groove. In particular, the invention protein fragments that inhibit cell proliferation, this activity requiring T-box interaction with target DNA's major groove, but not target DNA's minor groove.
Transcription Factors That Regulate Normal And Malignant Cell Growth
The invention provides TBX5 protein fragments that regulate normal and malignant cell growth and nucleic acids encoding these fragments. Such protein fragments include a translated 5′ T-box sequence capable of binding to the major groove of target DNA and lack a translated 3′ T-box sequence that binds to target DNA's minor groove. In particular, the invention protein fragments that inhibit cell proliferation, this activity requiring T-box interaction with target DNA's major groove, but not target DNA's minor groove.
Use Of Il-1 Beta Binding Antibodies To Treat Peripheral Arterial Disease
Craig Basson - Needham MA, US Kerry Russell - Waltham MA, US
International Classification:
C07K 16/24
Abstract:
The present invention relates to method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1β binding antibody or functional fragment thereof.
Use Of Il-1 Beta Binding Antibodies For Treating Peripheral Arterial Disease
Craig Basson - Needham MA, US Mark Fishman - Newton Center MA, US Tom Thuren - Succasunna NJ, US Shi Yin Foo - Brookline MA, US
Assignee:
Novartis AG - Basel
International Classification:
C07K 16/24
Abstract:
The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1β binding antibody or functional fragment thereof.
Boston Pharmaceuticals
Chief Medical Officer
Novartis Institutes For Biomedical Research (Nibr) 2010 - 2014
Vice President, Global Translational Medicine Head
Weill Cornell Medical College 1997 - 2010
Gladys and Roland Harriman Professor of Medicine; Director, Cardiovascular Research
Harvard Medical School 1996 - 1997
Instructor In Medicine
Brigham and Women's Hospital 1992 - 1996
Fellow In Cardiovascular Disease
Education:
Yale University School of Medicine 1984 - 1990
Doctor of Medicine, Doctorates, Doctor of Philosophy, Medicine
University of Oxford 1982 - 1984
Master of Science, Masters
Washington University In St. Louis 1979 - 1982
Masters, Master of Arts, Bachelors, Bachelor of Arts, Biology, French
Roslyn High School
Skills:
Translational Medicine Cardiovascular Disease Clinical Research Clinical Trials Medicine Clinical Development Healthcare Life Sciences Pharmaceutical Industry Lifesciences Molecular Biology Cardiology Cardiovascular Medicine Human Genetics Oncology Genetics Internal Medicine Biotechnology Neuroscience Medical Education Immunology Infectious Diseases Epidemiology Cancer Drug Development Hospitals Clinical Pharmaceuticals
Aug 2010 to 2000 Account Manager, Strategic PartnersKAPLAN COLLEGE Thornton, CO Dec 2009 to Aug 2010 Admission RepresentativeCOLORADO TECHNICAL UNIVERSITY Denver, CO Jul 2007 to Apr 2009 Director of AdmissionsCOLORADO TECHNICAL UNIVERSITY
May 2006 to Jul 2007 Associate DirectorCOLORADO TECHNICAL UNIVERSITY
Jul 2005 to May 2006 Admission RepresentativeWESTWOOD COLLEGE Denver, CO Jul 2003 to Jul 2005 Admission RepresentativeSHORTLINE AUTOMOTIVE Aurora, CO Apr 2003 to Jul 2003 Special Finance ConsultantPRO CHRYSLER JEEP Thornton, CO Oct 2001 to Apr 2003 Team ManagerPRO CHRYSLER JEEP
Aug 2002 to Aug 2002 Team ManagerAAMCO TRANSMISSION Denver, CO Jun 2001 to Oct 2001 Sales Manager Colorado RegionVOLT STAFFING SERVICES Denver, CO Sep 2000 to Mar 2001 Sales ConsultantNOVARTIS PHARMACEUTICALS Denver, CO Jan 1997 to Sep 2000 Medical Sales ConsultantNOVARTIS PHARMACEUTICALS East Hanover, NJ Jan 1994 to Sep 2000 Account Manager/Customer ServiceNOVARTIS PHARMACEUTICALS
Sep 1994 to Jan 1997 Corporate Account ManagerNOVARTIS PHARMACEUTICALS
Jan 1994 to Sep 1994 Retail Account Manager
Education:
Colorado Technical University Denver, CO Sep 2007 MBA in ExecutiveFort Lewis College Durango, CO May 1988 B. A. in Business Administration